Ladenburg Thalmann Financial Services’s Genetic Technologies Ltd. GENE Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio GENE Stock Details GENE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-138	Closed	-$3K	–	5374
2018 Q3	$3K	Hold	138	–	–	﹤0.01%	4808
2018 Q2	$3K	Hold	138	–	–	﹤0.01%	4799
2018 Q1	$3K	Hold	138	–	–	﹤0.01%	4799
2017 Q4	$3K	Hold	138	–	–	﹤0.01%	4715
2017 Q3	$2K	Hold	138	–	–	﹤0.01%	4707
2017 Q2	$2K	Hold	138	–	–	﹤0.01%	4633
2017 Q1	$3K	Hold	138	–	–	﹤0.01%	4487
2016 Q4	$3K	Hold	138	–	–	﹤0.01%	4453
2016 Q3	$5K	Hold	138	–	–	﹤0.01%	4189
2016 Q2	$6K	Hold	138	–	–	﹤0.01%	4067
2016 Q1	$6K	Hold	138	–	–	﹤0.01%	4010
2015 Q4	$7K	Hold	138	–	–	﹤0.01%	3906
2015 Q3	$5K	Hold	138	–	–	﹤0.01%	3960
2015 Q2	$8K	Buy	+138	New	+$11.6K	﹤0.01%	3837

Other funds holding GENE

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Cutler Group San Francisco, California $307M AUM 45.11% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

RBC Europe London, United Kingdom $2.08B AUM 12.2% 1-Year Est. Return

Ladenburg Thalmann Financial Services's GENE Position: Q4 2018 in Review

Ladenburg Thalmann Financial Services sold out of Genetic Technologies Ltd. (GENE) in Q4 2018, closing a stake of 138 shares — an estimated $3K sold.

Ladenburg Thalmann Financial Services first reported a position in GENE in Q2 2015 and held it in 14 quarters. The position peaked at $8K in Q2 2015. 11 funds tracked by Wall St. Rank hold GENE as of Q4 2018.

Ladenburg Thalmann Financial Services reported no remaining Genetic Technologies Ltd. position as of Q4 2018 after selling out during the quarter.
Ladenburg Thalmann Financial Services sold 138 Genetic Technologies Ltd. shares in Q4 2018, an estimated $3K.
Ladenburg Thalmann Financial Services first reported a position in Genetic Technologies Ltd. in Q2 2015 and held it in 14 quarters.
Ladenburg Thalmann Financial Services's Genetic Technologies Ltd. position peaked at $8K in Q2 2015.
11 funds tracked by Wall St. Rank held Genetic Technologies Ltd. as of Q4 2018.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2018, filed 14 Feb 2019.